TLX · Telix Pharmaceuticals Ltd

$11.75 -0.07 (-0.59%)

Market Cap

$4.00B

338.78M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-05-11	Jellison William R	Director	Other↑	No Securities Owned	0	—	—	0
2026-05-11	GILL DAVID N	Director	Other↑	No Securities Owned	0	—	—	0
2026-05-11	Rivas Maria	Director	Other↑	No Securities Owned	0	—	—	0
2026-04-29	Behrenbruch Christian	Director, MD & Group CEO	Buy↑ Filing footnotes — Ordinary Shares (Indirect) The purchase prices are reported in Australian Dollars. The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4. Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.	Ordinary Shares (I)	33,435	$14.87	$497,178	20,742,935
2026-04-28	Behrenbruch Christian	Director, MD & Group CEO	Buy↑ Filing footnotes — Ordinary Shares (Indirect) The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The purchase prices are reported in Australian Dollars. Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.	Ordinary Shares (I)	34,500	$14.48	$499,560	20,709,500
2026-03-29	Smith Darren Charlton	Group Chief Financial Officer	Convert↓ Filing footnotes — Share Rights (Direct) The share rights (SRs) were granted on January 1, 2025 and became vested and exercisable on March 5, 2026.	Share Rights	1,111	—	—	0
2026-03-29	Smith Darren Charlton	Group Chief Financial Officer	Convert↑	Ordinary Shares	1,111	—	—	11,921

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–7 of 7 transactions

Key facts CIK 2007191 CUSIP 87961M105 13F (30d) 58 filings 58 filers Visit website Investor relations